Skip to content Skip to navigation

Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004

TitlePrimary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004
Publication TypeJournal Article
Year of Publication2008
AuthorsJim, MA, Perdue, DG, Richardson, LC, Espey, DK, Redd, JT, Martin, HJ, Kwong, SL, Kelly, JJ, Henderson, JA, Ahmed, F
Date PublishedSep 1
ISBN Number0008-543X (Print)<br/>0008-543X (Linking)
Accession Number18720380
KeywordsAdenocarcinoma/ ethnology, Adolescent, Adult, Aged, Aged, 80 and Over, Alaska/epidemiology, Child, Child, Preschool, Continental Population Groups/statistics & numerical data, Female, Humans, Incidence, Indians, North American/ statistics & numerical data, Infant, Infant, Newborn, Inuits/ statistics & numerical data, Liver Neoplasms/ ethnology, Middle Aged, Population Surveillance, Registries, United States/epidemiology
AbstractBACKGROUND: American Indians and Alaska Natives (AI/AN) experience higher morbidity and mortality from primary liver cancer than other United States (US) populations, but racial misclassification in medical records results in underestimates of disease burden. METHODS: To reduce misclassification, National Program of Cancer Registries and Surveillance, Epidemiology, and End Results data were linked with Indian Health Service (IHS) enrollment records to compare primary liver cancer incidence and stage at diagnosis between AI/AN and non-Hispanic whites (NHW) living within the regionalized IHS Contract Health Service Delivery Area counties. Incidence rates are expressed per 100,000 persons and age-adjusted by 19 age groups to the 2000 US standard population. RESULTS: Overall, AI/AN have a higher proportion of hepatocellular carcinoma compared with NHW, 77.8% versus 66.7%. Liver cancer incidence rates among AI/AN males and females were higher than those among NHW males and females for all regions except for the East. Among males, rates ranged from 7.3 (95% confidence interval [CI], 3.8-12.6) in the East to 17.2 (95% CI, 10.4-26.3) in Alaska. Among females, rates ranged from 3.8 (95% CI, 1.4-8.2) in the East to 6.9 (95% CI, 3.6-11.6) in Alaska. The AI/AN rates for all regions were consistently higher than the NHW rates at every age. An increasing trend among AI/AN was suggested but did not achieve statistical significance. CONCLUSIONS: Reducing racial misclassification revealed higher disparities in primary liver cancer incidence between NHW and AI/AN populations than previously reported. Further description of the reasons for regional differences in this disparity is needed, as are programs to reduce risk factors and to diagnose primary liver cancer at earlier, more treatable stages.
Ethno Med: